Erin M Siegel1, Paul B Jacobsen2, Ji-Hyun Lee3, Mokenge Malafa4, William Fulp3, Michelle Fletcher2, Jesusa Corazon R Smith5, Richard Brown6, Richard Levine7, Thomas Cartwright8, Guillermo Abesada-Terk9, George Kim10, Carlos Alemany11, Douglas Faig12, Philip Sharp13, Merry-Jennifer Markham14, David Shibata4. 1. Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL. Electronic address: Erin.Siegel@moffitt.org. 2. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. 3. Department of Biostatistics, Moffitt Cancer Center, Tampa, FL. 4. Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL. 5. Center for Cancer Care & Research/Watson Clinic, Lakeland, FL. 6. Florida Cancer Specialists/Sarasota Memorial Hospital, Sarasota, FL. 7. Space Coast Medical Associates, Titusville, FL. 8. Ocala Oncology Center, Ocala, FL. 9. Robert & Carol Weissman Cancer Center at Martin Memorial, Stuart, FL. 10. Mayo Clinic, Jacksonville, FL. 11. Florida Institute of Research, Medicine, and Surgery, Orlando, FL. 12. North Broward Medical Center, Deerfield Beach, FL. 13. Tallahassee Memorial Healthcare, Tallahassee, FL. 14. University of Florida/Shands Cancer Center, Gainesville, FL.
Abstract
BACKGROUND: The quality of cancer care has become a national priority; however, there are few ongoing efforts to assist medical oncology practices in identifying areas for improvement. The Florida Initiative for Quality Cancer Care is a consortium of 11 medical oncology practices that evaluates the quality of cancer care across Florida. Within this practice-based system of self-assessment, we determined adherence to colorectal cancer quality of care indicators (QCIs) in 2006, disseminated results to each practice and reassessed adherence in 2009. The current report focuses on evaluating the direction and magnitude of change in adherence to QCIs for colorectal cancer patients between the 2 assessments. STUDY DESIGN: Medical records were reviewed for all colorectal cancer patients seen by a medical oncologist in 2006 (n = 489) and 2009 (n = 511) at 10 participating practices. Thirty-five indicators were evaluated individually and changes in QCI adherence over time and by site were examined. RESULTS: Significant improvements were noted from 2006 to 2009, with large gains in surgical/pathological QCIs (eg, documenting rectal radial margin status, lymphovascular invasion, and the review of ≥ 12 lymph nodes) and medical oncology QCIs (documenting planned treatment regimen and providing recommended neoadjuvant regimens). Documentation of perineural invasion and radial margins significantly improved; however, adherence remained low (47% and 71%, respectively). There was significant variability in adherence for some QCIs across institutions at follow-up. CONCLUSIONS: The Florida Initiative for Quality Cancer Care practices conducted self-directed quality-improvement efforts during a 3-year interval and overall adherence to QCIs improved. However, adherence remained low for several indicators, suggesting that organized improvement efforts might be needed for QCIs that remained consistently low over time. Findings demonstrate how efforts such as the Florida Initiative for Quality Cancer Care are useful for evaluating and improving the quality of cancer care at a regional level.
BACKGROUND: The quality of cancer care has become a national priority; however, there are few ongoing efforts to assist medical oncology practices in identifying areas for improvement. The Florida Initiative for Quality Cancer Care is a consortium of 11 medical oncology practices that evaluates the quality of cancer care across Florida. Within this practice-based system of self-assessment, we determined adherence to colorectal cancer quality of care indicators (QCIs) in 2006, disseminated results to each practice and reassessed adherence in 2009. The current report focuses on evaluating the direction and magnitude of change in adherence to QCIs for colorectal cancerpatients between the 2 assessments. STUDY DESIGN: Medical records were reviewed for all colorectal cancerpatients seen by a medical oncologist in 2006 (n = 489) and 2009 (n = 511) at 10 participating practices. Thirty-five indicators were evaluated individually and changes in QCI adherence over time and by site were examined. RESULTS: Significant improvements were noted from 2006 to 2009, with large gains in surgical/pathological QCIs (eg, documenting rectal radial margin status, lymphovascular invasion, and the review of ≥ 12 lymph nodes) and medical oncology QCIs (documenting planned treatment regimen and providing recommended neoadjuvant regimens). Documentation of perineural invasion and radial margins significantly improved; however, adherence remained low (47% and 71%, respectively). There was significant variability in adherence for some QCIs across institutions at follow-up. CONCLUSIONS: The Florida Initiative for Quality Cancer Care practices conducted self-directed quality-improvement efforts during a 3-year interval and overall adherence to QCIs improved. However, adherence remained low for several indicators, suggesting that organized improvement efforts might be needed for QCIs that remained consistently low over time. Findings demonstrate how efforts such as the Florida Initiative for Quality Cancer Care are useful for evaluating and improving the quality of cancer care at a regional level.
Keywords:
CRC; FIQCC; Florida Initiative for Quality Cancer Care; LN; LVI; NICCQ; National Initiative for Cancer Care Quality; PNI; QCI; QOPI; Quality Oncology Practice Initiative; colorectal cancer; lymph node; lymphovascular invasion; perineural invasion; quality of care indicator
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Carlos Alemany; Guillermo Abesada-Terk; Richard Brown; Thomas Cartwright; Douglas Faig; George Kim; Richard Levine; Merry-Jennifer Markham; Fred Schreiber; Philip Sharp; Mokenge Malafa Journal: Psychooncology Date: 2010-09-27 Impact factor: 3.894
Authors: Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone Journal: J Clin Oncol Date: 2005-08-08 Impact factor: 44.544
Authors: Michael O Idowu; Leonas G Bekeris; Stephen Raab; Stephen G Ruby; Raouf E Nakhleh Journal: Arch Pathol Lab Med Date: 2010-07 Impact factor: 5.534
Authors: C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett Journal: Arch Pathol Lab Med Date: 2000-07 Impact factor: 5.534
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Mihaela Druta; Ji-Hyun Lee; Jan Marshburn; Linda Davenport; Hugh Cruse; Richard Levine; Avantica Gondi; Richard Brown; Mokenge Malafa Journal: J Oncol Pract Date: 2007-03 Impact factor: 3.840
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; Carlos A Alemany; Richard Brown; Thomas H Cartwright; Richard M Levine; Jesusa Corazon R Smith; Guillermo Abesada-Terk; Mokenge P Malafa Journal: Cancer Control Date: 2009-10 Impact factor: 3.302
Authors: Erin M Siegel; Paul B Jacobsen; Mokenge Malafa; William Fulp; Michelle Fletcher; Ji-Hyun Lee; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata Journal: J Oncol Pract Date: 2012-06-12 Impact factor: 3.840
Authors: Paul B Jacobsen; Ji-Hyun Lee; William Fulp; Erin M Siegel; David Shibata; Christine Laronga; Jhanelle Gray; Tawee Tanvetyanon; Fred Schreiber; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; Mokenge Malafa Journal: J Oncol Pract Date: 2014-10-28 Impact factor: 3.840